Selinexor in Combination with Bortezomib and Dexamethasone (SVd) Demonstrates Significant Activity in Patients with Refractory MM: Results of Phase I STOMP Trial (MCRN02)
Selinexor in Combination with Bortezomib and Dexamethasone (SVd) Demonstrates Significant Activity in Patients with Refractory MM: Results of Phase I STOMP Trial (MCRN02)